Frédéric Guerard

Frédéric Guerard currently works at Qlaris Bio, Inc., as President, Chief Executive Officer & Director from 2026, Unither Pharmaceuticals LLC, as Non-Executive Director, Spiral Therapeutics, Inc., as Independent Director, LENZ Therapeutics Operations, Inc., as Director from 2021, CalciMedica, Inc., as Non-Executive Director from 2023, and LENZ Therapeutics, Inc., as Independent Director from 2024.
Dr. Guerard also formerly worked at Ceryvyn Therapeutics Ltd., as Chief Executive Officer from 2023 to 2025, Graybug Vision, Inc., as President, Chief Executive Officer & Director, The Association of the British Pharmaceutical Industry, as Director, Medicines Australia, as Director, Novartis AG, as Head-Ophthalmology from 2016 to 2019, and Alcon Vision LLC, as Head-Global Franchise Pharmaceuticals from 2015 to 2016.
Dr. Guerard received his graduate degree from École des Hautes Études Commerciales de Paris and graduate degree and doctorate degree from Université de Rouen Normandie.